Krill Oil for Health & Longevity - Quick Reference Sheet
evipedia.ai ← Back

Krill Oil for Health & Longevity

Created on 07/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 – Audit

Krill oil is a highly absorbable marine omega-3 source. Its strongest evidence is lowering blood fats and raising omega-3 status, often at smaller doses than fish oil. It modestly eases knee joint pain and inflammation. Well tolerated aside from mild digestive upset; unsuitable for those with shellfish allergy. Longevity claims remain unproven, and it is costly. (Full Review)

Protocol

Dose
1–4 g/day
≈200–600 mg combined EPA and DHA; dose by omega-3 delivered, not capsule count
Timing
With a fatty meal
Take with the largest fat-containing meal of the day for absorption and tolerability
Schedule
Start low, split
Begin ~1 g/day and split larger doses across meals; titrate toward 2–4 g/day
Time to effect
Blood fats
4–12 weeks
Triglyceride reduction emerges
Omega-3 status
8–12 weeks
Omega-3 Index approaches a new steady state
Joint pain
4–12 weeks
Knee pain relief when present; judge after 2–3 months

Benefits

Contraindications
  • Shellfish or crustacean allergy
  • Active bleeding disorders
  • Scheduled surgery (within ~7 days)
    •
Key Interactions
  • Anticoagulants and antiplatelets (warfarin, apixaban, rivaroxaban, aspirin, clopidogrel)
  • High-dose NSAIDs (ibuprofen, naproxen)
  • Other omega-3 sources (fish oil, algal oil, concentrates)
  • Antiplatelet supplements (vitamin E, ginkgo, garlic, high-dose curcumin)
  • Orlistat
    •

Risk & Side Effects

  • High: Mild gastrointestinal effects
    •
  • Medium: Allergic reaction in shellfish-sensitive individuals; increased bleeding risk at high doses
    •
  • Low: Adverse metabolic shifts at very high doses; product oxidation and rancidity
    •
  • Speculative: Immune modulation concerns; contaminant exposure
    •

Monitoring

Marker Target Why
Omega-3 Index 8–12% Tracks membrane EPA and DHA; primary success marker
Triglycerides < 90 mg/dL Best-supported krill oil effect
hs-CRP < 1.0 mg/L (optimal < 0.5) Gauges systemic inflammation response
LDL cholesterol < 100 mg/dL (context-dependent) Detects the conflicted lipid effect
HDL cholesterol > 50 mg/dL May rise modestly with omega-3s
HbA1c / fasting glucose HbA1c < 5.4% / glucose < 90 mg/dL Screens for the rare high-dose metabolic shift

Cadence: Recheck the Omega-3 Index and a lipid panel at ~12 weeks after starting, then every 6–12 months once stable; inflammatory and metabolic markers follow the same 6–12 month rhythm.

Qualitative Assessment

  • Fewer or less intense joint aches and better morning stiffness
  • Perceived exercise recovery and muscle soreness
  • Energy levels and general well-being
  • Cognitive clarity and mood
  • Absence of digestive side effects, indicating good tolerability
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.